By identifying abnormally expressed proteins in the eye, a Stanford-led team matched existing drugs with these proteins to quell patients' symptoms.
Consider it a pre-Thanksgiving brain teaser. The image at the right is something called an autostereogram -- a three-dimensional picture that can be seen only by …
“Every one of us has a passion to improve human health,” said Lloyd Minor, MD, dean of Stanford’s medical school, as he welcomed participants to …
The transition from health to illness remains little understood, but it is a critical component of efforts to begin predicting and preventing disease, the goal …
The Project Baseline study is an ambitious endeavor with a potentially transformative payoff. Launched in April after years of designing and planning by Verily, an Alphabet …
If you live close to an old-fashioned ice cream parlor (like I do), then you're more likely to indulge than if, say, you live near …
It can take years for a researcher studying a rare disease to collect enough patient data to begin the analysis phase of a study. But …
Once someone has a stroke, the likelihood for a second stroke jumps up. And that recurrent stroke may cause further damage to the already injured …
Clinical trials, in their current incarnation, are ill-suited for the nimble, personalized precision health era, a a panel of speakers at the Big Data in …
Your fitness tracker knows how fast your heart beats when you bicycle to work and how your heart flip-flops when your sweetie surprises you with a kiss. …
Perhaps you're familiar (or very familiar) with PubMed, the go-to database for biomedical research. Or, perhaps you've spent a rainy Sunday exploring historical anatomical images. …
American Heart Association CEO Nancy Brown began her career at the AHA three decades ago, when heart health was defined by healthy eating, exercise and …
Stanford Medicine's vision of precision health is taking shape in exciting, and perhaps unexpected, ways, Dean Lloyd Minor, MD, wrote in a recent Fortune commentary. As …
Confronted in 2002 by a medical record that was literally two feet in height, Stanford hematologist Jason Gotlib, MD, had no idea that his career path …
Glioblastoma multiforme is a deadly brain tumor with few good treatment options. Until recently, physicians had hoped that tackling the cancer with a specific type of …
When Allyssa Lawson was an infant, her doctors at Lucile Packard Children's Hospital Stanford struggled to understand her unusual symptoms. Allyssa, who was born in …
